GSK’s ViiV, Horizon and Pfizer earn top scores from U.S. patient groups: survey

When it comes to sizing up pharma’s corporate reputation, U.S. patient groups put GlaxoSmithKline’s ViiV Healthcare, Horizon Therapeutics and Pfizer on top. | When it comes to sizing up pharma’s corporate reputation, U.S. patient groups put GlaxoSmithKline’s ViiV Healthcare, Horizon Therapeutics and Pfizer on top.